Bloomberg Intelligence cover image

Novo Nordisk Gets US Approval for Wegovy Obesity Pill 

Bloomberg Intelligence

00:00

Reporter analysis: milestone for Novo Nordisk

John Tazzi (John Tazi) explains the milestone, timing versus Eli Lilly, and potential market expansion.

Play episode from 05:13
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app